85 Segment

81 Family

31 Class

08 Commodity

Introduction of other therapeutic substance into biliary and pancreatic tract, via natural or artificial opening endoscopic

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 85813100
Below: 0
Links · KBLI: 8

Definition

UNSPSC 85813108

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of other therapeutic substance into biliary and pancreatic tract, via natural or artificial opening endoscopic.This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0J8GC

Same parent

Under 85813100 · 34

85813101 Introduction of nonautologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813102 Introduction of autologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813103 Introduction of destructive agent into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813104 Introduction of other gas into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813105 Introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813106 Introduction of other diagnostic substance into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813107 Introduction of radioactive substance into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813108 Introduction of other therapeutic substance into biliary and pancreatic tract, via natural or artificial opening endoscopic You are here 85813109 Introduction of local anesthetic into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813110 Introduction of electrolytic and water balance substance into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813111 Introduction of nutritional substance into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813112 Introduction of anti-inflammatory into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813113 Introduction of other anti-infective into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813114 Introduction of oxazolidinones into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813115 Introduction of monoclonal antibody into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813116 Introduction of other antineoplastic into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813117 Introduction of liquid brachytherapy radioisotope into biliary and pancreatic tract, via natural or artificial opening endoscopic Commodity 85813118 Introduction of nonautologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening Commodity 85813119 Introduction of autologous pancreatic islet cells into biliary and pancreatic tract, via natural or artificial opening Commodity 85813120 Introduction of destructive agent into biliary and pancreatic tract, via natural or artificial opening Commodity 85813121 Introduction of other gas into biliary and pancreatic tract, via natural or artificial opening Commodity 85813122 Introduction of analgesics, hypnotics, sedatives into biliary and pancreatic tract, via natural or artificial opening Commodity 85813123 Introduction of other diagnostic substance into biliary and pancreatic tract, via natural or artificial opening Commodity 85813124 Introduction of radioactive substance into biliary and pancreatic tract, via natural or artificial opening Commodity 85813125 Introduction of other therapeutic substance into biliary and pancreatic tract, via natural or artificial opening Commodity 85813126 Introduction of local anesthetic into biliary and pancreatic tract, via natural or artificial opening Commodity 85813127 Introduction of electrolytic and water balance substance into biliary and pancreatic tract, via natural or artificial opening Commodity 85813128 Introduction of nutritional substance into biliary and pancreatic tract, via natural or artificial opening Commodity 85813129 Introduction of anti-inflammatory into biliary and pancreatic tract, via natural or artificial opening Commodity 85813130 Introduction of other anti-infective into biliary and pancreatic tract, via natural or artificial opening Commodity 85813131 Introduction of oxazolidinones into biliary and pancreatic tract, via natural or artificial opening Commodity 85813132 Introduction of monoclonal antibody into biliary and pancreatic tract, via natural or artificial opening Commodity 85813133 Introduction of other antineoplastic into biliary and pancreatic tract, via natural or artificial opening Commodity 85813134 Introduction of liquid brachytherapy radioisotope into biliary and pancreatic tract, via natural or artificial opening Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 85810000.

75002 Aktivitas Pengelolaan Sarana Kesehatan Hewan Sub-class 86101 Aktivitas Rumah Sakit Pemerintah Sub-class 86102 Aktivitas Puskesmas Sub-class 86103 Aktivitas Rumah Sakit Swasta Sub-class 86104 Aktivitas Klinik Pemerintah Sub-class 86105 Aktivitas Klinik Swasta Sub-class 86109 Aktivitas Rumah Sakit Lainnya Sub-class 86202 Aktivitas Praktik Dokter Spesialis Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.